CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus Inc. (NASDAQ: ZLCS) presented data today on its discovery of novel synergistic drug combinations for the treatment of cancer at the Targeted Cancer Therapies World Europe 2010 meeting in Zurich on September 23, 2010. During her talk, Margaret Lee, Ph.D., Vice President of Research at Zalicus discussed the role of chemical biology and genomics data in driving hypothesis generation applicable to patient selection and combination therapeutic development.
